• COVID-19
  • THEMES
  • USAID INVESTMENTS
  • SPECIAL FOCUS AREAS
    • Corporate TB Pledge
    • Urban Health
    • Inclusive Development
  • PHC INNOVATIONS
  • LEARNING LIBRARY
  • DATA VISUALIZATION

This section hosts guidelines, manuals and toolkits to strengthen public health practice.

Resources

FILTER
BY CATEGORY

View All

COVID-19 Stay Tuned Nutrition For implementers For policymakers Report For researchers Research Urban Health M&E

EXPLORE DATA
VISUALIZATIONS

Explore key data on health and its determinants in India through interactive graphs.

Associations of BMI with COVID-19 vaccine uptake, vaccine effectiveness, and risk of severe COVID-19 outcomes after vaccination in England: a population-based cohort study

07 Jul 2022
Emerging Pandemics

by Carmen Piernas, Martina Patone, Nerys M Astbury, Min Gao, Aziz Sheikh, Kamlesh Khunti, Manu Shankar-Hari, Sharon Dixon, Carol Coupland, Paul Aveyard, Julia Hippisley-Cox, Susan A Jebb 30 MIN

It is vital that all individuals with a higher risk of developing severe COVID-19, including those who are overweight or obese, are protected, as COVID-19 vaccines have demonstrated significant levels of protection against both mild and severe COVID-19 in the general population. As obesity impairs the reaction to immunizations, there is evidence that the efficiency of the seasonal influenza vaccine, among other infectious diseases, is lower in obese individuals than in individuals of a healthy weight. Therefore, it is important to research how well COVID-19 vaccinations work in obese people so that, in the event that different responses are found, alternate risk management strategies for infectious respiratory disorders might be used in this population. According to this extensive community-based cohort study, adults with overweight and obese who receive vaccinations are more protected against serious COVID-19. This extensive community-based cohort study shows that vaccination increases protection against severe COVID-19 in those with overweight and obese. Underweight individuals were shown to have reduced effectiveness, and their absorption of the vaccine was also much lower. When compared to the vaccinated population who were of a healthy weight, there were higher chances of severe COVID-19 outcomes in the vaccinated cohort for those who were obese or underweight. These findings point to the need for focused initiatives to boost uptake among those with low BMI, where it is lower and vaccine efficacy appears to be diminished. At the population level, strategies for achieving and maintaining a healthy weight should be prioritized as they may lessen the burden of COVID-19 disease.

Related File :

2854716918.pdf

Categories

COVID-19
KEY ORGANIZATIONS
Connect with Us
Subscribe to the Newsletter

FOLLOW US

  • HOME
  • THEMES
  • USAID INVESTMENTS
  • SPECIAL FOCUS AREAS
  • LEARNING LIBRARY
  • DATA VISUALIZATION
  • ABOUT US
  • CONTACT US
  • PRIVACY POLICY
Disclaimer: This website is made possible by the support of the American People through the United States Agency for International Development (USAID). The Learning4impact partnership is supported by USAID/India Health Office, under Cooperative Agreement # 72038618CA00001 with Swasti. The information provided on this website is not official U.S. Government information and does not necessarily represent the views or positions of USAID, the United States Government, or Swasti.
Copyright 2025 Swasti Health Catalyst

Subscribe to the Newsletter

Submit Feedback

  • COVID-19
  • THEMES
  • USAID INVESTMENTS
  • SPECIAL FOCUS AREAS
    • Corporate TB Pledge
    • Urban Health
    • Inclusive Development
  • PHC INNOVATIONS
  • LEARNING LIBRARY
  • DATA VISUALIZATION